6,273
Participants
Start Date
August 31, 1999
Primary Completion Date
May 31, 2012
Study Completion Date
May 31, 2012
No intervention
At six-month intervals (January and July), physicians will document disease characteristics, changes in Crohn's therapy, disease progression, key events, the use of ancillary services, and hospitalizations
Lead Sponsor
Janssen Biotech, Inc.
INDUSTRY